Between the two centers, no significant difference in clinical characteristics (age, gender, tumor location, tumor morphology, parenchymal atrophy, dilatation of pancreatic duct, preoperative CA19-9, CA125, CEA, nerve invasion and vascular invasion and AJCC TNM Stage. This evidence concerns the gene CEACAM5 and neoplasm.